Literature DB >> 2176889

Patterns of strongly protein-associated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons.

C G Shin1, R M Snapka.   

Abstract

Exposure of infected CV-1 cells to specific type I and type II topoisomerase poisons caused strong protein association with distinct subsets of simian virus 40 (SV40) DNA replication intermediates. On the basis of the known specificity and mechanisms of action of these drugs, the proteins involved are assumed to be the respective topoisomerases. Camptothecin, a topoisomerase I poison, caused strong protein association with form II (relaxed circular) and form III (linear) viral genomes and replication intermediates having broken DNA replication forks but not with form I (superhelical) viral DNA or normal late replication intermediates which were present. In contrast, type II topoisomerase poisons caused completely replicated forms and late viral replication forms to be tightly bound to protein--some to a greater extent than others. Different type II topoisomerase inhibitors caused distinctive patterns of protein association with the replication intermediates present. Both intercalating and nonintercalating type II topoisomerase poisons caused a small amount of form I (superhelical) SV40 DNA to be protein-associated in vivo. The protein complex with form I viral DNA was entirely drug-dependent and strong, but apparently noncovalent. The protein associated with form I DNA may represent a drug-stabilized "topological complex" between type II topoisomerase and SV40 DNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176889     DOI: 10.1021/bi00501a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Precise localization of the alpha-globin gene cluster within one of the 20- to 300-kilobase DNA fragments released by cleavage of chicken chromosomal DNA at topoisomerase II sites in vivo: evidence that the fragments are DNA loops or domains.

Authors:  S V Razin; P Petrov; R Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Distribution of topoisomerase II-mediated cleavage sites and relation to structural and functional landmarks in 830 kb of Drosophila DNA.

Authors:  R Miassod; S V Razin; R Hancock
Journal:  Nucleic Acids Res       Date:  1997-06-01       Impact factor: 16.971

3.  Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I.

Authors:  J L Zhang; P L Sharma; C J Li; B J Dezube; A B Pardee; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

4.  Human topoisomerase I promotes initiation of simian virus 40 DNA replication in vitro.

Authors:  P W Trowbridge; R Roy; D T Simmons
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Aphidicolin-induced topological and recombinational events in simian virus 40.

Authors:  R M Snapka; C G Shin; P A Permana; J Strayer
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

6.  Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.

Authors:  J Roca; R Ishida; J M Berger; T Andoh; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.